Festschrift: Peter Beighton

Duchenne muscular dystrophy in the Western Cape, South Africa: Where do we come from and where are we going?

A I Esterhuizen, L J Greenberg, R Ballo, R G Goliath, J M Wilmshurst

Abstract


Duchenne muscular dystrophy (DMD) is one of the most common and severe of the inherited dystrophies, with an incidence of 1 in 3 500 live, male births worldwide. Becker muscular dystrophy (BMD) has a lower incidence of 1:14 000 - 18 000 boys and a milder progression and longer life expectancy. Over the last two decades, better understanding of the underlying disease aetiology as well as major advances in medical technology have brought about significantly improved genetic diagnosis and clinical care for B/DMD patients. Exciting developments in the field of gene-based therapies have once again put B/DMD in the limelight, with renewed focus on the importance of comprehensive genetic testing protocols. We present a historical overview of the medical and molecular service for B/DMD offered over the last three decades in South Africa, specifically in the Western Cape, from a clinical as well as a laboratory perspective.

 

Authors' affiliations

A I Esterhuizen, Division of Human Genetics, Department of Pathology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town; and National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa

L J Greenberg, Division of Human Genetics, Department of Pathology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa

R Ballo, Division of Human Genetics, Department of Pathology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa; and Division of Cell Biology, Department of Human Biology, Faculty of Medicine, University of Cape Town, South Africa

R G Goliath, Division of Human Genetics, Department of Pathology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa; and National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa

J M Wilmshurst, Division of Human Genetics, Department of Pathology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa; and Department of Paediatric Neurology and Neurophysiology, Red Cross War Memorial Children’s Hospital, University of Cape Town, South Africa

Full Text

PDF (330KB)

Cite this article

South African Medical Journal 2016;106(6):S67. DOI:10.7196/SAMJ.2016.v106i6.10999

Article History

Date submitted: 2016-05-06
Date published: 2016-05-25

Article Views

Abstract views: 3110
Full text views: 1632

Comments on this article

*Read our policy for posting comments here